Skip to main content

Renaissance Technologies LLC

SEC CIK
0001037389
Latest filing
Aug 13, 2026

CGEM holding history

Cullinan Therapeutics, Inc. in every 13F filed by Renaissance Technologies LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CGEM overviewAll 13F holders of CGEMFull Q2 2026 holdings

Shares (Q2 2026)
326,811
Value
$5.95M
% of portfolio
<0.1%
Quarters held
19
Since Q2 2021
Holdings of CGEM by Renaissance Technologies LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026326,811$5.95M<0.1%+2,700+0.8%AddedHolders
Q1 2026324,111$4.61M<0.1%−307,595−48.7%ReducedHolders
Q4 2025631,706$6.54M<0.1%+102,298+19.3%AddedHolders
Q3 2025529,408$3.14M<0.1%+194,883+58.3%AddedHolders
Q2 2025334,525$2.52M<0.1%−28,483−7.8%ReducedHolders
Q1 2025363,008$2.75M<0.1%+172,500+90.5%AddedHolders
Q4 2024190,508$2.32M<0.1%−91,292−32.4%ReducedHolders
Q3 2024281,800$4.72M<0.1%−139,908−33.2%ReducedHolders
Q2 2024421,708$7.35M<0.1%+100,608+31.3%AddedHolders
Q1 2024321,100$5.47M<0.1%+57,012+21.6%AddedHolders
Q4 2023264,088$2.69M<0.1%+41,388+18.6%AddedHolders
Q3 2023222,700$2.02M<0.1%−22,900−9.3%ReducedHolders
Q2 2023245,600$2.64M<0.1%+6,400+2.7%AddedHolders
Q1 2023239,200$2.45M<0.1%−68,500−22.3%ReducedHolders
Q4 2022307,700$3.25M<0.1%+5,505+1.8%AddedHolders
Q3 2022302,195$3.87M<0.1%+8,595+2.9%AddedHolders
Q2 2022293,600$3.76M<0.1%+293,600NewHolders
Q1 20220$00.0%−26,600−100.0%Sold outHolders
Q4 202126,600$410.0K<0.1%+26,600NewHolders
Q3 20210$00.0%−25,982−100.0%Sold outHolders
Q2 202125,982$669.0K<0.1%+25,982NewHolders